Document Detail


Mitral valve prolapse.
MedLine Citation:
PMID:  6144281     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Mitral valve prolapse is a very common condition. It occurs in 4-5% of the population. It may be idiopathic or associated with a number of other conditions. Myxomatous degeneration is the underlying mechanism of mitral valve prolapse. Most patients with mitral valve prolapse have no symptoms. When symptoms do occur, palpitations, chest pain and dyspnea are the major complaints. The midsystolic click occasionally followed by the late systolic murmur are the typical physical findings. The echocardiogram plays a big role in the diagnosis of mitral valve prolapse. The beta blockers are used in the treatment of the symptomatic patient.
Authors:
L Gould; C Gopalaswamy
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Angiology     Volume:  35     ISSN:  0003-3197     ISO Abbreviation:  Angiology     Publication Date:  1984 May 
Date Detail:
Created Date:  1984-06-08     Completed Date:  1984-06-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0203706     Medline TA:  Angiology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  290-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use
Coronary Angiography
Echocardiography
Female
Heart / radionuclide imaging
Heart Catheterization
Heart Murmurs
Humans
Male
Mitral Valve Prolapse / diagnosis*,  drug therapy,  pathology
Myocardial Contraction
Phonocardiography
Prognosis
Radioisotopes / diagnostic use
Thallium / diagnostic use
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Radioisotopes; 7440-28-0/Thallium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of alfentanyl in short-term anesthesia. Initial results
Next Document:  Blepharospasm: demographic and clinical survey of 250 patients.